Published in J Proteome Res on April 14, 2007
ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother (2008) 1.30
Fungicidal drugs induce a common oxidative-damage cellular death pathway. Cell Rep (2013) 1.19
Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Chemother (2008) 1.06
Systems biology of fungal infection. Front Microbiol (2012) 1.04
Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrob Agents Chemother (2010) 1.02
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicans. Proteomics Clin Appl (2009) 0.76
Transcriptional response of Candida albicans biofilms following exposure to 2-amino-nonyl-6-methoxyl-tetralin muriate. Acta Pharmacol Sin (2010) 0.75
The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IkappaBalpha expression. Circ Res (2009) 2.04
cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother (2005) 1.48
C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity (2013) 1.46
Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med (2005) 1.21
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother (2006) 1.08
Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res (2009) 1.07
Antifungal activities and action mechanisms of compounds from Tribulus terrestris L. J Ethnopharmacol (2005) 1.06
Lipotoxicity in HepG2 cells triggered by free fatty acids. Am J Transl Res (2011) 0.96
Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents. Biol Pharm Bull (2013) 0.94
Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Antimicrob Agents Chemother (2013) 0.93
RTA2, a novel gene involved in azole resistance in Candida albicans. Biochem Biophys Res Commun (2008) 0.92
In vitro and in vivo activities of pterostilbene against Candida albicans biofilms. Antimicrob Agents Chemother (2014) 0.88
In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens. Biol Pharm Bull (2005) 0.86
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51). Eur J Med Chem (2007) 0.86
Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats. J Hypertens (2005) 0.86
Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction. Biol Pharm Bull (2007) 0.86
Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs. Eur J Pharmacol (2006) 0.85
cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients. Int J Med Microbiol (2006) 0.85
Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. Pharmacol Biochem Behav (2007) 0.84
Effect of tetrandrine against Candida albicans biofilms. PLoS One (2013) 0.84
CaIPF7817 is involved in the regulation of redox homeostasis in Candida albicans. Biochem Biophys Res Commun (2007) 0.83
Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p. PLoS One (2012) 0.83
Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats. World J Gastroenterol (2005) 0.82
Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling. Biol Pharm Bull (2006) 0.82
ECM17-dependent methionine/cysteine biosynthesis contributes to biofilm formation in Candida albicans. Fungal Genet Biol (2012) 0.81
Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis. Clin Exp Pharmacol Physiol (2009) 0.80
Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling. Pharmacol Res (2005) 0.80
Effect of esculentoside A on autoimmunity in mice and its possible mechanisms. Acta Pharmacol Sin (2002) 0.80
Baicalein induces programmed cell death in Candida albicans. J Microbiol Biotechnol (2009) 0.80
Effects of esculentoside A on production of interleukin-1, 2, and prostaglandin E2. Acta Pharmacol Sin (2004) 0.80
High-frequency genetic contents variations in clinical Candida albicans isolates. Biol Pharm Bull (2011) 0.80
Asynchronism of the recovery of baroreflex sensitivity, blood pressure, and consciousness from anesthesia in rats. J Cardiovasc Pharmacol (2004) 0.80
cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicans. Acta Biochim Biophys Sin (Shanghai) (2005) 0.78
Proteomic analysis of Rta2p-dependent raft-association of detergent-resistant membranes in Candida albicans. PLoS One (2012) 0.78
The role of pattern recognition receptors in the innate recognition of Candida albicans. Virulence (2015) 0.77
In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine. Biol Pharm Bull (2005) 0.77
Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein. Int J Antimicrob Agents (2006) 0.77
Cap1p plays regulation roles in redox, energy metabolism and substance transport: an investigation on Candida albicans under normal culture condition. Front Biosci (2007) 0.77
PalI domain proteins of Saccharomyces cerevisiae and Candida albicans. Microbiol Res (2012) 0.77
In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent. Biol Pharm Bull (2006) 0.76
Novel triazolyl berberine derivatives prepared via CuAAC click chemistry: synthesis, anticancer activity and structure-activity relationships. Anticancer Agents Med Chem (2015) 0.76
Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions. J Ethnopharmacol (2007) 0.76
Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Clin Sci (Lond) (2005) 0.76
Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14 alpha-demethylase (CYP51). Chem Biodivers (2007) 0.76
Ste18p is a positive control element in the mating process of Candida albicans. Eukaryot Cell (2014) 0.76
Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Biol Pharm Bull (2007) 0.76
Cap1p attenuates the apoptosis of Candida albicans. FEBS J (2013) 0.75
Synthesis and evaluation of novel 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substitutedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents. Eur J Med Chem (2006) 0.75
[Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans]. Yao Xue Xue Bao (2014) 0.75
TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans. J Med Microbiol (2010) 0.75
[Rapid detection of four antipertensive chemicals adulterated in traditional Chinese medicine for hypertension using TLC-SERS]. Guang Pu Xue Yu Guang Pu Fen Xi (2014) 0.75